Einstein International Journal Organization(EIJO)

ABSTRACT 

The nanotubes may consist of one up to tens and hundreds of concentric shells of carbons with adjacent shells separation of 0.34 nm. The carbon network of the shells is closely related to the honeycomb arrangement of the carbon atoms in the graphite sheets. Cancer is a generic term that encompasses a group of diseases characterized by an uncontrolled proliferation of cells. There are over 200 different types of cancer, each of which gains its nomenclature according to the type of tissue the cell originates in. Many patients who succumb to cancer do not die as a result of the primary tumor, but because of the systemic effects of metastases on other regions away from the original site. One of the aims of cancer therapy is to prevent the metastatic process as early as possible. There are currently many therapies in clinical use, and recent advances in biotechnology lend credence to the potential of nanotechnology in the fight against cancer. Nanomaterials such as carbon nanotubes (CNTs), quantum dots, and dendrimers have unique properties that can be exploited for diagnostic purposes, thermal ablation, and drug delivery in cancer. CNTs are tubular materials with nanometer-sized diameters and axial symmetry, giving them unique properties that can be exploited in the diagnosis and treatment of cancer. In addition, CNTs have the potential to deliver drugs directly to targeted cells and tissues. Alongside the rapid advances in the development of nanotechnology-based materials, elucidating the toxicity of nanoparticles is also imperative. Hence, in this review, we seek to explore the biomedical applications of CNTs, with particular emphasis on their use as therapeutic platforms in oncology.

[1]. Westlake S, Cooper N. Cancer incidence and mortality: Trends in the United Kingdom and constituent countries, 1993 to 2004. Health Stat Q. 2008;38:33–46.

[2]. Utreja P, Jain S, Tiwary AK. Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: Current status and future prospects.  Drug Delivery, 2010;7:152–161.

[3]. Batra R, Davies JN, Wheatley D. Extensive arterial and venous thrombo-embolism with chemotherapy for testicular cancer: A case report. Cases J. 2009; 2:9082.

[4].Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc. 2008;130: 11467–11476.

[5]. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68:6652–6660.

[6].  S. Iijima, “Helical microtubules of graphitic carbon,” Nature, vol. 354, no. 6348, pp. 56–58, 1991. 

[7]. R. Hirlekar, M. Yamagar, H. Garse, M. Vij, and V. Kadam, “Carbon nanotubes and its applications: a review,” Asian Journal of Pharmaceutical and Clinical Research, vol. 2, no. 4, pp. 17–27, 2009. 

[8]. B. G. P. Singh, C. Baburao, V. Pispati et al., “Carbon nanotubes. A novel drug delivery system,”International Journal of Research in Pharmacy and Chemistry, vol. 2, no. 2, pp. 523–532, 2012.

[9].Y. Zhang, Y. Bai, and B. Yan, “Functionalized carbon nanotubes for potential medicinal applications,”Drug Discovery Today, vol. 15, no. 11-12, pp. 428–435, 2010. 

[10]. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68:6652–6660.

[11]. R. Hirlekar, M. Yamagar, H. Garse, M. Vij, and V. Kadam, “Carbon nanotubes and its applications: a review,” Asian Journal of Pharmaceutical and Clinical Research, vol. 2, no. 4, pp. 17–27, 2009

[12]. B. G. P. Singh, C. Baburao, V. Pispati et al., “Carbon nanotubes. A novel drug delivery system,”International Journal of Research in Pharmacy and Chemistry, vol. 2, no. 2, pp. 523–532, 2012.

[13].  Z. Liu, X. Sun, N. Nakayama-Ratchford, and H. Dai, “Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery,” ACS Nano, vol. 1, no. 1, pp. 50–56, 2007.

[14]. E. Bekyarova, Y. Ni, E. B. Malarkey, et al., “Applications of carbon nanotubes in biotechnology and biomedicine,” Journal of Biomedical Nanotechnology, vol. 1, no. 1, pp. 3–17, 2005.

[15]. Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc. 2008;130:11467–11476

[16]. G. Prenciple, et al J Am Chem Soc, 131 (2009), p. 4783

[17]. W. Zhang, Z. Zhang, and Y. Zhang, “The application of carbon nanotubes in target drug delivery systems for cancer therapies,” Nanoscale Research Letters, vol. 6, pp. 555–577, 2011

[18]. H. Liao, B. Paratala, B. Sitharaman, and Y. Wang, “Applications of carbon nanotubes in biomedical studies,” Methods in Molecular Biology, vol. 726, pp. 223–241, 2011.

[19]. A. M. A. Elhissi, W. Ahmed, I. U. Hassan, V. R. Dhanak, and A. D'Emanuele, “Carbon nanotubes in cancer therapy and drug delivery,” Journal of Drug Delivery, vol. 2012, Article ID 837327, 10 pages, 2012.

[20]. W. Zhang, Z. Zhang, and Y. Zhang, “The application of carbon nanotubes in target drug delivery systems for cancer therapies,” Nanoscale Research Letters, vol. 6, pp. 555–577, 2011.

[21]. S. Y. Madani, N. Naderi, O. Dissanayake, A. Tan, and A. M. Seifalian, “A    new era of cancer treatment: carbon nanotubes as drug delivery tools,” International Journal of  Nanomedicine, vol. 6, pp. 2963–2979, 2011. 

[22]. A. M. A. Elhissi, W. Ahmed, I. U. Hassan, V. R. Dhanak, and A. D'Emanuele, “Carbon nanotubes in cancer therapy and drug delivery,” Journal of Drug Delivery, vol. 2012, Article ID 837327, 10 pages, 2012.

[23]. M. S. Digge, R. S. Moon, and S. G. Gattani, “Applications of carbon nanotubes in drug delivery: a review,” International Journal of PharmTech Research, vol. 4, no. 2, pp. 839–847, 2012

[24]. Graphene and carbon nanotube nanocomposite for gene transfection. Materials Science and Engineering: C 39: 288–298.

[25]. M. S. Digge, R. S. Moon, and S. G. Gattani, “Applications of carbon nanotubes in drug delivery: a review,” International Journal of PharmTech Research, vol. 4, no. 2, pp. 839–847, 2012

[26].W. Yang, P. Thordarson, J. J. Gooding, S. P. Ringer, and F. Braet, “Carbon nanotubes for biological and biomedical applications,” Nanotechnology, vol. 18, Article ID 412001, 12 pages, 2007

[27].Y. Chang, S. Yang, J. Liu et al., “In vitro toxicity evaluation of graphene oxide on A549 cells,” Toxicology Letters, vol. 200, no. 3, pp. 201–210, 2011

[28]. C. P. Firme III and P. R. Bandaru, “Toxicity issues in the application of carbon nanotubes to biological systems,” Nanomedicine, vol. 6, no. 2, pp. 245–256, 2010.

[29]. S. Yang, J. Luo, Q. Zhou, and H. Wang, “Pharmacokinetics, metabolism and toxicity of carbon nanotubes for bio-medical purposes,” Theranostics, vol. 2, no. 3, pp. 271–282, 2012.